TRIZIVIR (State of Florida DOH Central Pharmacy)
Welcome to the PulseAid listing for the TRIZIVIR drug offered from State of Florida DOH Central Pharmacy. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | State of Florida DOH Central Pharmacy |
| NON-PROPRIETARY NAME: | abacavir sulfate, lamivudine, and zidovudine |
| SUBSTANCE NAME: | ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-02-01 |
| END MARKETING DATE: | 0000-00-00 |
TRIZIVIR HUMAN PRESCRIPTION DRUG Details:
| Item Description | TRIZIVIR from State of Florida DOH Central Pharmacy |
| LABELER NAME: | State of Florida DOH Central Pharmacy |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300; 150; 300(mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2013-02-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 53808-0990_a6299f1c-1ddb-4da4-a38d-2cb34eca0c02 |
| PRODUCT NDC: | 53808-0990 |
| APPLICATION NUMBER: | NDA021205 |
Other ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE Pharmaceutical Manufacturers / Labelers:
